Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 8 reviews

538%
425%
338%
20%
10%
Ask AI

Ask AI about Q2pharma

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Q2pharma

Q2pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) bacteria to be used as adjuvant medication with commonly used antibiotics or a standalone medication.

Our lead compound, F19 has shown promise in combating deadly MDR bacterial infections. Whereas antibiotics kill bacteria, as an antivirulent, F19 inhibits bacterial toxin release, allowing the immune system to do its job more effectively. F19 has been shown to potentiate antibiotic efficacy, even to antibiotics that the pathogen is otherwise resistant. Recent experiments have demonstrated F19s potent effects on several of the most common and deadly MDR bacteria.

Categories
Pharmaceuticals